What is NDC 75834-220?

75834-220 is the product NDC for Carbamazepine, Carbamazepine 100 mg/1 tablet, listed with the FDA by NIVAGEN PHARMACEUTICALS, INC.. It has 2 package NDCs, shown above in 10- and 11-digit form.

NIVAGEN PHARMACEUTICALS, INC., NDC labeler code 75834. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Carbamazepine?

133 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Carbamazepine NDC 75834-220 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)75834-220Labeler and product segments. Claims need a package NDC.

Product NDC at billing width75834-0220Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
75834-220-00	7583402200075834022000	1000 TABLET in 1 BOTTLE (75834-220-00)Marketed from Apr 21, 2020
75834-220-01	7583402200175834022001	100 TABLET in 1 BOTTLE (75834-220-01)Marketed from Apr 21, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Carbamazepine
Generic name (nonproprietary): carbamazepine
Active ingredients: Carbamazepine — 100 mg/1
Dosage form: Tablet
Route: Oral
Labeler: NIVAGEN PHARMACEUTICALS, INC.NDC labeler code 75834
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207798
Marketing start: Apr 21, 2020
Listing expires: Dec 31, 2027
Other FDA classes: Cytochrome P450 1A2 Inducers (Mechanism)Cytochrome P450 2B6 Inducers (Mechanism)Cytochrome P450 2C19 Inducers (Mechanism)Cytochrome P450 2C9 Inducers (Mechanism)Cytochrome P450 3A4 Inducers (Mechanism)Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 75834-220_5cad93e2-6a7b-0244-e063-6294a90a5d9fSPL ID 5cad93e2-6a7b-0244-e063-6294a90a5d9f
Pharmacologic class: Mood Stabilizer

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N475834022000 followed by a unit qualifier and the quantity

Package 75834-0220-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 75834-220

What is NDC 75834-220?: 75834-220 is the product NDC for Carbamazepine, Carbamazepine 100 mg/1 tablet, listed with the FDA by NIVAGEN PHARMACEUTICALS, INC.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Carbamazepine.
What is the active ingredient?: Carbamazepine.
Who is the labeler?: NIVAGEN PHARMACEUTICALS, INC., NDC labeler code 75834. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Carbamazepine?: 133 other product NDCs are listed under this name. See all Carbamazepine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Carbamazepine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Carbamazepine	Carbamazepine 100 mg/5mL	SuspensionOral	Precision Dose, Inc.	68094-125	68094-0125-62
Carbamazepine	Carbamazepine 100 mg/5mL	SuspensionOral	Precision Dose, Inc.	68094-225	68094-0225-62
Carbamazepine	Carbamazepine 100 mg/1	Tablet, Extended releaseOral	American Health Packaging	60687-973	60687-0973-21
Carbamazepine	Carbamazepine 200 mg/1	TabletOral	REMEDYREPACK INC.	70518-4682	70518-4682-00
Carbamazepine	Carbamazepine 100 mg/1	Tablet, ChewableOral	Coupler LLC	67046-0753	67046-0753-03
Carbamazepine	Carbamazepine 200 mg/1	TabletOral	Coupler LLC	67046-0707	67046-0707-03
Carbamazepine	Carbamazepine 100 mg/1	Capsule, Extended releaseOral	ANI Pharmaceuticals, Inc.	62559-484	62559-0484-12
Carbamazepine	Carbamazepine 200 mg/1	Capsule, Extended releaseOral	ANI Pharmaceuticals, Inc.	62559-485	62559-0485-12
Carbamazepine	Carbamazepine 300 mg/1	Capsule, Extended releaseOral	ANI Pharmaceuticals, Inc.	62559-486	62559-0486-12
Carbamazepine	Carbamazepine 200 mg/1	Tablet, Extended releaseOral	Northstar Rx LLC	72603-887	72603-0887-01

All 134 Carbamazepine NDCs

Other NDCs under ANDA 207798

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207798
Product	Strength	Form · route	Labeler	Product NDC
Carbamazepine	Carbamazepine 200 mg/1	TabletOral	A-S Medication Solutions	50090-5740
Carbamazepine	Carbamazepine 200 mg/1	TabletOral	Umedica Laboratories USA Inc.	60290-008
Carbamazepine	Carbamazepine 100 mg/1	TabletOral	Umedica Laboratories USA Inc.	60290-034
Carbamazepine	Carbamazepine 200 mg/1	TabletOral	Coupler LLC	67046-0707
Carbamazepine	Carbamazepine 200 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-7825
Carbamazepine	Carbamazepine 200 mg/1	TabletOral	REMEDYREPACK INC.	70518-2841
Carbamazepine	Carbamazepine 200 mg/1	TabletOral	Bryant Ranch Prepack	71335-1730
Carbamazepine	Carbamazepine 200 mg/1	TabletOral	direct rx	72189-157
Carbamazepine	Carbamazepine 200 mg/1	TabletOral	NIVAGEN PHARMACEUTICALS, INC.	75834-221